Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), sold 77,730 shares at $12.31 ($957K) on 2017-09-29, disclosed to the SEC on 2017-09-29.
Open-market sale of $957k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.31 | 38,865 | $478K | 50.0% |
| 2 | $12.31 | 38,865 | $478K | 50.0% |
| Total | $12.31 avg | 77,730 | $957K | 100% |
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |
| MGEN | SELL | 2017-03-13 | $83K | — | Filing → |